Oncologists Market Report 2025

The oncologists market size has grown marginally in recent years. It will grow from $19.93 billion in 2024 to $20.3 billion in 2025 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, awareness and early detection programs.

The oncologists market size is expected to see steady growth in the next few years. It will grow to $24.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, emerging therapeutic modalities, global oncology collaboration, epidemiological shifts and new challenges, healthcare policy and economic factors. Major trends in the forecast period include immunotherapy advancements, precision medicine integration, telemedicine expansion, data-driven decision-making, collaborative care models, and patient-centric care.

The increasing prevalence of cancer is expected to significantly drive the growth of the oncologists market in the future. Cancer is a disease characterized by the uncontrolled growth of certain body cells, which can then spread to other areas. The prevalence of cancer refers to the number of new cases that occur in a specified population over a specific period. Oncologists are healthcare professionals specializing in the diagnosis and treatment of cancer; they are responsible for examining patients, diagnosing the disease, and identifying treatment options. For example, in May 2024, the National Cancer Institute, a U.S.-based government agency, reported that there were approximately 18.1 million cancer survivors in the United States. This number is projected to rise to 22.5 million by 2032. Furthermore, by 2040, the annual incidence of new cancer cases is expected to reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the rising prevalence of cancer is propelling the oncologists market forward.

The growth of the aging population is expected to be a significant factor supporting the expansion of the oncologists' market. An aging population, comprising individuals aged 60 and above, is more susceptible to cancer as the risk of cancer increases with age. The demand for oncologists rises with the growing prevalence of cancer in the elderly population. According to the World Health Organization, by 2030, 1 in 6 people globally will be aged 60 or above. The number of elderly individuals reached 1.4 billion in 2020, and by 2050, it is projected to more than double, reaching 2.1 billion. Therefore, the increasing size of the aging population is expected to have a positive impact on the oncologists' market in the forecast period.

Major companies in the oncology market are focusing on establishing AI-precision oncology centers to enhance personalized cancer treatment, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers are specialized medical facilities that employ artificial intelligence (AI) and machine learning technologies to deliver highly personalized cancer care. For example, in January 2024, Apollo Cancer Centre, an India-based hospital, launched its AI-precision oncology center. This facility aims to support oncologists, patients, and caregivers in achieving optimal outcomes within a defined timeframe by harnessing the capabilities of AI technology. The center uses AI technologies to provide precise diagnoses and real-time insights into patient conditions, enabling timely interventions and better management of cancer cases. Additionally, the center conducts comprehensive cancer risk assessments to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

Major companies in the oncologists' market are also establishing new collaborative networks to advance research and development efforts. In September 2023, Amgen launched the 'Amgen Partners of Choice' network, bringing together its oncology research and development experts with clinical leaders at eight global research centers. The network, part of Amgen's mission to enhance care through partnerships, fosters academic collaboration to advance innovative treatment options for patients with significant unmet needs.

In July 2024, Mumbai Oncocare (MOC) Cancer Care & Research Centre, an India-based hospital and physician clinic specializing in oncology care, merged with Hemato Oncology Clinic for an undisclosed amount. This merger enables Mumbai Oncocare to enhance its portfolio by leveraging Hemato Oncology's expertise, which includes a total of 40 medical oncologists and hematologists. Hemato Oncology Clinic is an India-based facility that provides advanced oncology care.

Major companies operating in the oncologists market include Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité - Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

North America was the largest region in the oncologists market in 2024. The regions covered in the oncologists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncologists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Oncologists are a specialized type of healthcare practitioner focused on the diagnosis and treatment of cancer. They play a crucial role in evaluating patients, diagnosing cancer, and recommending appropriate treatments, actively participating in the comprehensive care of cancer patients.

The primary areas of focus for oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics involve testing procedures designed to confirm the presence of cancer and identify the specific tumor type. Common cancer types include lung cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, and prostate cancer. Oncologists work in various healthcare settings, including hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia, and other related institutions.

The oncologists market research report is one of a series of new reports that provides oncologists market statistics, including oncologists industry global market size, regional shares, competitors with an oncologists market share, detailed oncologists market segments, market trends and opportunities, and any further data you may need to thrive in the oncologists industry. This mobile wallet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.